See more : PT Provident Agro Tbk (PALM.JK) Income Statement Analysis – Financial Results
Complete financial analysis of China Medicine Corporation (CHME) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Medicine Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
- Belpointe PREP, LLC (OZ) Income Statement Analysis – Financial Results
- Analog Devices, Inc. (ANL.DE) Income Statement Analysis – Financial Results
- The Commercial Bank (P.S.Q.C.) (CBQK.QA) Income Statement Analysis – Financial Results
- Fjordkraft Holding ASA (FKRFT.OL) Income Statement Analysis – Financial Results
- Astra Microwave Products Limited (ASTRAMICRO.BO) Income Statement Analysis – Financial Results
China Medicine Corporation (CHME)
About China Medicine Corporation
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
| Metric | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|
| Revenue | 64.75M | 53.65M | 42.11M | 23.99M | 0.00 | 10.40M |
| Cost of Revenue | 45.77M | 38.07M | 29.71M | 15.02M | 0.00 | 7.16M |
| Gross Profit | 18.98M | 15.57M | 12.40M | 8.97M | 0.00 | 3.24M |
| Gross Profit Ratio | 29.32% | 29.03% | 29.44% | 37.41% | 0.00% | 31.16% |
| Research & Development | 1.45M | 840.44K | 651.99K | 294.08K | 0.00 | 527.97K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 214.68K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 80.84K |
| SG&A | 5.26M | 3.80M | 3.33M | 1.57M | 32.50K | 295.52K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.72M | 4.65M | 3.98M | 2.79M | 32.50K | 823.50K |
| Cost & Expenses | 52.48M | 42.72M | 33.69M | 17.81M | 32.50K | 7.98M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.01M | 420.77K | 784.11K | 162.05K | 0.00 | 122.02K |
| EBITDA | 13.28M | 11.35M | 9.20M | 6.35M | -32.50K | 2.54M |
| EBITDA Ratio | 31.80% | 20.99% | 21.81% | 31.17% | 0.00% | 24.31% |
| Operating Income | 12.27M | 10.93M | 8.41M | 6.18M | -32.50K | 2.42M |
| Operating Income Ratio | 18.94% | 20.37% | 19.98% | 25.78% | 0.00% | 23.25% |
| Total Other Income/Expenses | -7.31M | 85.62K | 15.42K | -199.95K | 2.55M | 12.91K |
| Income Before Tax | 4.95M | 11.01M | 8.43M | 5.98M | 0.00 | 2.43M |
| Income Before Tax Ratio | 7.65% | 20.53% | 20.02% | 24.94% | 0.00% | 23.37% |
| Income Tax Expense | 3.55M | 2.01M | 1.65M | 1.23M | 32.50K | -509.03K |
| Net Income | 1.72M | 9.13M | 6.88M | 4.79M | -32.50K | 2.94M |
| Net Income Ratio | 2.65% | 17.01% | 16.33% | 19.96% | 0.00% | 28.27% |
| EPS | 0.11 | 0.60 | 0.56 | 0.65 | -0.01 | 0.41 |
| EPS Diluted | 0.11 | 0.60 | 0.50 | 0.63 | -0.01 | 0.39 |
| Weighted Avg Shares Out | 15.27M | 15.17M | 12.35M | 7.35M | 6.53M | 7.25M |
| Weighted Avg Shares Out (Dil) | 15.41M | 15.31M | 13.66M | 7.65M | 6.53M | 7.56M |
Source: https://incomestatements.info
Category: Stock Reports